Niacin and Lipoprotein(a): Facts, Uncertainties, and Clinical Considerations
- 17 April 2008
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 101 (8), S44-S47
- https://doi.org/10.1016/j.amjcard.2008.02.031
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Present-day uses of niacin: effects on lipid and non-lipid parametersExpert Opinion on Pharmacotherapy, 2007
- Niacin in cardiovascular prevention: mechanisms, efficacy, and safetyCurrent Opinion in Lipidology, 2007
- Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary reviewJournal of Internal Medicine, 2005
- Niacin and cholesterol: role in cardiovascular disease (review)The Journal of Nutritional Biochemistry, 2003
- Evaluating niacin in its various formsThe American Journal of Cardiology, 2000
- A new extended-release niacin (niaspan): efficacy, tolerability, and safety in hypercholesterolemic patientsThe American Journal of Cardiology, 1998
- Efficacy and safety of an extended-release niacin (niaspan): a long-term studyThe American Journal of Cardiology, 1998
- Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acidJournal of Internal Medicine, 1989
- Clofibrate and Niacin in Coronary Heart DiseasePublished by American Medical Association (AMA) ,1975
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955